Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05151406

Myths and Misconceptions About HSCT in a Limited Resource Region

Hematopoietic Stem Cell Transplantation Clinical Trial

Official title:
Myths and Misconceptions About HSCT in a Limited Resource Region: Current Situation and Future Directions

Clinical Trial Summary

This study aimed to assess myths and misconceptions about hematopoietic stem cell transplantation, among students of medical colleges and to evaluate the value of an educational program in correcting those misconceptions. 218 undergraduate medical and nursing students included in this study. An intervention Quasi Experimental study design (pre/post-test) was used for this work.

Clinical Trial Description

This study aimed to assess myths and misconceptions about hematopoietic stem cell transplantation, among students of medical colleges and to evaluate the value of an educational program in correcting those misconceptions. The last aim was to detect further needs for advancement of health education about bone marrow transplantation at Assiut University. Study subjects: two groups, Group 1: 5th year undergraduate medical students(118 students), Group 2: 4th year undergraduate nursing students(100 students). Each group were randomly selected . Both groups 1 and 2 assumed to have knowledge about BMT from their study courses, also they represent a sector from the general population that could be involved in a BMT team in their future career. this work that was conducted at Assiut University Faculties of Medicine and Nursing at Assiut Governorate during the period from July 2019 to May 2020. The subject's inclusion criteria were: - Willingness to participate in the study - Good ECOG performance status - Intact physical and mental health And the Exclusion criteria were: - HSCT team - Drug users ;

Study Design

Related Conditions & MeSH terms

  • Hematopoietic Stem Cell Transplantation
Clinical Trial Details
NCT number NCT05151406
Study type Interventional
Source Assiut University
Contact
Status Completed
Phase N/A
Start date October 6, 2021
Completion date December 17, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT00766883 - Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant Phase 2
Recruiting NCT06148610 - Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Recruiting NCT04690933 - AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
Completed NCT02564458 - Fitness in Allogeneic Stem Cell Transplantation N/A
Recruiting NCT02543073 - MSC for Treatment of Interstitial Lung Disease After Allo-HSCT Phase 1/Phase 2
Not yet recruiting NCT01714557 - Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation N/A
Completed NCT00701688 - Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Phase 1
Completed NCT00023530 - Blood and Marrow Transplant Clinical Research Network N/A
Recruiting NCT04092309 - Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation N/A
Completed NCT00000603 - Cord Blood Stem Cell Transplantation Study (COBLT) Phase 2
Completed NCT02663622 - Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002) Phase 2
Recruiting NCT04937634 - Pharmacokinetic Study of Melphalan in Pediatric Hematopoietic Stem Cell Transplantation Phase 1
Recruiting NCT04203108 - ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis Phase 4
Withdrawn NCT03279133 - Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients. Phase 4
Completed NCT03654599 - Effects of Digital Stories Intervention on Psychosocial Well-being N/A
Completed NCT02241005 - Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci N/A
Recruiting NCT03689465 - PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis Phase 4
Recruiting NCT04868786 - Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation Phase 1
Recruiting NCT03010579 - Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation Phase 4
Active, not recruiting NCT00959140 - Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors N/A